Newtyn Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,021,500
| Closed | -$9.19M | – | 49 |
|
|
2023
Q4 | $9.19M | Buy |
3,021,500
+521,056
| +21% | +$1.58M | 1.8% | 18 |
|
|
2023
Q3 | $7.1M | Buy |
2,500,444
+1,142,395
| +84% | +$3.24M | 1.75% | 16 |
|
|
2023
Q2 | $3.53M | Buy |
1,358,049
+405,102
| +43% | +$1.05M | 0.83% | 27 |
|
|
2023
Q1 | $1.73M | Sell |
952,947
-67,053
| -7% | -$122K | 0.34% | 51 |
|
|
2022
Q4 | $1.68M | Buy |
1,020,000
+365,888
| +56% | +$604K | 0.35% | 40 |
|
|
2022
Q3 | $1.26M | Buy |
654,112
+47,864
| +8% | +$91.9K | 0.28% | 47 |
|
|
2022
Q2 | $1.81M | Buy |
+606,248
| New | +$1.81M | 0.34% | 45 |
|